BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1044 related articles for article (PubMed ID: 30871597)

  • 41. Outcomes and prognostic stratification of patients with recurrent glioblastoma treated with salvage stereotactic radiosurgery.
    Sharma M; Schroeder JL; Elson P; Meola A; Barnett GH; Vogelbaum MA; Suh JH; Chao ST; Mohammadi AM; Stevens GHJ; Murphy ES; Angelov L
    J Neurosurg; 2018 Oct; 131(2):489-499. PubMed ID: 30485180
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The efficacy and limitations of stereotactic radiosurgery as a salvage treatment after failed whole brain radiotherapy for brain metastases.
    Yomo S; Hayashi M
    J Neurooncol; 2013 Jul; 113(3):459-65. PubMed ID: 23661101
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Prognostic factors for overall survival after radiosurgery for brain metastases from melanoma.
    Marcus DM; Lowe M; Khan MK; Lawson DH; Crocker IR; Shelton JW; Melton A; Maynard N; Delman KA; Carlson GW; Rizzo M
    Am J Clin Oncol; 2014 Dec; 37(6):580-4. PubMed ID: 23428955
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Resection followed by stereotactic radiosurgery to resection cavity for intracranial metastases.
    Do L; Pezner R; Radany E; Liu A; Staud C; Badie B
    Int J Radiat Oncol Biol Phys; 2009 Feb; 73(2):486-91. PubMed ID: 18922650
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Radiosurgery to the surgical cavity as adjuvant therapy for resected brain metastasis.
    Robbins JR; Ryu S; Kalkanis S; Cogan C; Rock J; Movsas B; Kim JH; Rosenblum M
    Neurosurgery; 2012 Nov; 71(5):937-43. PubMed ID: 22806080
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Radiosurgery or hypofractionated stereotactic radiotherapy for brain metastases from radioresistant primaries (melanoma and renal cancer).
    Lesueur P; Lequesne J; Barraux V; Kao W; Geffrelot J; Grellard JM; Habrand JL; Emery E; Marie B; Thariat J; Stefan D
    Radiat Oncol; 2018 Jul; 13(1):138. PubMed ID: 30055640
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Stereotactic radiosurgery for patients with brain metastases from small cell lung cancer.
    Wegner RE; Olson AC; Kondziolka D; Niranjan A; Lundsford LD; Flickinger JC
    Int J Radiat Oncol Biol Phys; 2011 Nov; 81(3):e21-7. PubMed ID: 21345622
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Survival after surgery and stereotactic radiosurgery for patients with multiple intracranial metastases: results of a single-center retrospective study.
    Smith TR; Lall RR; Lall RR; Abecassis IJ; Arnaout OM; Marymont MH; Swanson KR; Chandler JP
    J Neurosurg; 2014 Oct; 121(4):839-45. PubMed ID: 24857242
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Outcome of moderately dosed radiosurgery for limited brain metastases. Report of a single-center experience.
    Meisner J; Meyer A; Polivka B; Karstens JH; Bremer M
    Strahlenther Onkol; 2010 Feb; 186(2):76-81. PubMed ID: 20127224
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Treatment of five or more brain metastases with stereotactic radiosurgery.
    Hunter GK; Suh JH; Reuther AM; Vogelbaum MA; Barnett GH; Angelov L; Weil RJ; Neyman G; Chao ST
    Int J Radiat Oncol Biol Phys; 2012 Aug; 83(5):1394-8. PubMed ID: 22209150
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Stereotactic radiosurgery for patients with multiple brain metastases: a case-matched study comparing treatment results for patients with 2-9 versus 10 or more tumors.
    Yamamoto M; Kawabe T; Sato Y; Higuchi Y; Nariai T; Watanabe S; Kasuya H
    J Neurosurg; 2014 Dec; 121 Suppl():16-25. PubMed ID: 25434933
    [TBL] [Abstract][Full Text] [Related]  

  • 52. HFSRT of the resection cavity in patients with brain metastases.
    Specht HM; Kessel KA; Oechsner M; Meyer B; Zimmer C; Combs SE
    Strahlenther Onkol; 2016 Jun; 192(6):368-76. PubMed ID: 26964777
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Post-operative stereotactic radiosurgery versus observation for completely resected brain metastases: a single-centre, randomised, controlled, phase 3 trial.
    Mahajan A; Ahmed S; McAleer MF; Weinberg JS; Li J; Brown P; Settle S; Prabhu SS; Lang FF; Levine N; McGovern S; Sulman E; McCutcheon IE; Azeem S; Cahill D; Tatsui C; Heimberger AB; Ferguson S; Ghia A; Demonte F; Raza S; Guha-Thakurta N; Yang J; Sawaya R; Hess KR; Rao G
    Lancet Oncol; 2017 Aug; 18(8):1040-1048. PubMed ID: 28687375
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Hypofractionated stereotactic radiotherapy (hfSRT) after tumour resection of a single brain metastasis: report of a single-centre individualized treatment approach.
    Steinmann D; Maertens B; Janssen S; Werner M; Frühauf J; Nakamura M; Christiansen H; Bremer M
    J Cancer Res Clin Oncol; 2012 Sep; 138(9):1523-9. PubMed ID: 22526164
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Surgical Resection of Brain Metastases and the Risk of Leptomeningeal Recurrence in Patients Treated With Stereotactic Radiosurgery.
    Johnson MD; Avkshtol V; Baschnagel AM; Meyer K; Ye H; Grills IS; Chen PY; Maitz A; Olson RE; Pieper DR; Krauss DJ
    Int J Radiat Oncol Biol Phys; 2016 Mar; 94(3):537-43. PubMed ID: 26867883
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Impact of radiation, systemic therapy and treatment sequencing on survival of patients with melanoma brain metastases.
    Rauschenberg R; Bruns J; Brütting J; Daubner D; Lohaus F; Zimmer L; Forschner A; Zips D; Hassel JC; Berking C; Kaehler KC; Utikal J; Gutzmer R; Terheyden P; Meiss F; Rafei-Shamsabadi D; Kiecker F; Debus D; Dabrowski E; Arnold A; Garzarolli M; Kuske M; Beissert S; Löck S; Linn J; Troost EGC; Meier F
    Eur J Cancer; 2019 Mar; 110():11-20. PubMed ID: 30739835
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Adverse radiation effect after stereotactic radiosurgery for brain metastases: incidence, time course, and risk factors.
    Sneed PK; Mendez J; Vemer-van den Hoek JG; Seymour ZA; Ma L; Molinaro AM; Fogh SE; Nakamura JL; McDermott MW
    J Neurosurg; 2015 Aug; 123(2):373-86. PubMed ID: 25978710
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Stereotactic radiosurgery for 318 brain metastases in a single Australian centre: the impact of histology and other factors.
    Sia J; Paul E; Dally M; Ruben J
    J Clin Neurosci; 2015 Feb; 22(2):303-7. PubMed ID: 25304434
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Evaluatıon of hypofractıonated stereotactıc radıotherapy (HFSRT) to the resectıon cavıty after surgıcal resectıon of braın metastases: A sıngle center experıence.
    Dincoglan F; Sager O; Uysal B; Demiral S; Gamsiz H; Gündem E; Elcim Y; Dirican B; Beyzadeoglu M
    Indian J Cancer; 2019; 56(3):202-206. PubMed ID: 31389381
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Whole brain radiotherapy versus stereotactic radiosurgery for 4-10 brain metastases: a phase III randomised multicentre trial.
    Zindler JD; Bruynzeel AME; Eekers DBP; Hurkmans CW; Swinnen A; Lambin P
    BMC Cancer; 2017 Jul; 17(1):500. PubMed ID: 28743240
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 53.